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ANNOUNCEMENTS 
Managing Epilepsy: A Workshop for People with 
Epilepsy and their Families 
22nd International Epilepsy Congress 
27-28 JUNE 1997 
Trinity College, Dublin 
Organised by the International Bureau for 
Epilepsy 
For people with epilepsy and other members of 
their family, this workshop will bring together 
experts in the field to discuss important issues in 
managing epilepsy today. 
The workshop will cover: 
l what is epilepsy 
l the needs of people with epilepsy 
l educational and employment issues 
l conventional and alternative treatments 
Cost: 2120 per person, to include registration, 
accommodation, lunch, tea and coffee. 
For further information, contact: 
Ann Jacoby 
University of Newcastle upon Tyne, UK 
Tel: 00 44 191222 7046 
Fax: 00 44 191222 6043 
e-mail: ann.jacoby@ncl.ac.uk 
Jacqui Berkeley 
Incentive Conference Ireland 
Tel: 00 353 1667 1711 
Fax: 00 353 1667 1713 
.- 
Educational Workshop on Epilepsy 
22nd International Epilepsy Congress 
27-28 JUNE 1997 
Trinity College, Dublin 
Organised by the International Bureau for 
Epilepsy 
Aimed at young professionals including doctors, 
nurses and social workers, this workshop will 
bring together experts in the field to provide an 
overview of key clinical and psychosocial issues in 
epilepsy care. Invited speakers include Professor 
David Chadwick, Professor Jerome Engel, MS 
Hanneke de Boer, Professor Pat Gibson. The 
workshop will cover: 
l treatment issues 
l systems of care 
l the role of the multidisciplinary team 
l family, educational and employment issues 
Cost: f120 per person, to include registration, 
accommodation, lunch, tea and coffee. 
For further information, contact: 
Ann Jacoby 
University of Newcastle upon Tyne, UK 
Tel: 00 44 191222 7046 
Fax: 00 44 191222 6043 
e-mail: ann.jacoby@ncl.ac.uk 
Jacqui Berkeley 
Incentive Conference Ireland 
Tel: 00 353 1667 1711 
Fax: 00 353 1667 1713 
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Fourth Eilat Conference on New Antiepileptic Drugs 
September 6-IO,1998 
Royal Beach Hotel, Eilat, Israel 
The program includes the following sessions: 
Session 1: Outcome Assessment in Epilepsy: 
Methodology and Challenges: 
1. Requirements for long-term efficacy out- 
come trials in epilepsy: Clinical perspective. C.E. 
Elger (Germany) 
2. Health-related quality of life in epilepsy: 
Can it be measured? J. Cramer (USA) 
3. Special problems related to the assessment 
of efficacy in infants and children. 0. Dulac 
(France) 
4. Limitations of the methods used to assess 
drug product safety and effectiveness: Regulatory 
perspectives. P. Leber (USA) 
5. Limitations of the methods used to assess 
drug product safety and effectiveness: Clinical 
Perspectives. H. Meinardi (The Netherlands) and 
J.A. French (USA). 
Session 2: Cost-Effectiveness Assessments: How 
and When? (Round Table): 
1. Regulatory perspectives 
2. Clinical perspectives. S. Shorvon (UK) 
3. Industry perspectives. S. Schwabe (Den- 
mark) and H.C. Rohde (Denmark). 
Session 3: Cost-Effectiveness of Recently Mark- 
eted Antiepileptic Drugs: 
1. Controversial Views. Con: JWAS Sander 
(UK); Pro: B. Schmidt (Germany). 
Session 4: Drugs in Development: 
1. Remacemide 
2. Rufinamide (CGP 33101) 
3. Levetiracetam (ucb LO 59) 
4. Losigamone 
5. D2916 
6. TV 1901 
7. D-231291 
8. Ganaxolone (CCD 1042). 
Session 5: Progress Report On and Recent Find- 
ings of Marketed Drugs (monotherapy, assess- 
ment of relevant side effects, the use of these new 
A EDs in non-epileptic syndromes, etc.) 
1. Felbamate 
2. Fosphenytoin 
3. Gabapentin 
4. Lamotrigine 
5. Oxcarbazepine 
6. Tiagabine 
7. Topiramate 
8. Vigabatrin 
9. Zonisamide 
10. Vagal Stimulation-a new antiepileptic 
device. 
Session 6: Controversies in Strategies for Drug 
Development 
1. The case for pursuing selectivity of action. 
J.L. Noebels (USA) 
2. The case for multiple mechanism of action. 
D. Schmidt (Germany) 
3. Can we prevent epileptogenesis? M.A. 
Dichter (USA) 
4. Prediction potential of preclinial models: 
lessons from the past. H.J. Kupferberg (USA) 
5. Rational approach to the prediction of 
metabolic drug interactions: a practical guide for 
the clinician. R.H. Levy (USA) 
6. Pharmacodynamic drug interactions: Can 
they be exploited to clinical benefit? L. Gram 
(Denmark). 
A limited number of free papers (posters) are 
accepted on a first come-first in basis. Organizing 
Committee: M. Blaler, Israel; S.I. Johannessen, 
Norway; H.J. Kupferberg, USA: R.H. Levy, 
USA; P. Loiseau, France; E. Perucca, Italy. 
Information: Conference Secretariat, P.O. Box 
29041, Tel Aviv 61290, Israel. 
Tel: 972-3-5175149/50. 
Fax: 972-3-5175155. 
